New cancer drug duo enters human testing
NCT ID NCT07073534
Summary
This study is testing a new combination of two drugs, SHR-1501 and adbelizumab, for people with advanced or metastatic cancers that have stopped responding to standard treatments. The main goals are to find the safest and most effective dose and to see if the combination can shrink tumors. It will enroll about 203 adults to first test safety and then see how well the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510000, China
Contact
Conditions
Explore the condition pages connected to this study.